Literature DB >> 29349732

Membranous glomerulonephritis with an LMNA mutation.

Kumi Fujita1, Kazuhiro Hatta2.   

Abstract

We had encountered the case of membranous glomerulonephritis (MGN) with dilated cardiomyopathy due to LMNA gene mutation. LMNA mutation was known as a cause of 'laminopathy' such as dilated cardiomyopathy, muscular dystrophy, neuropathy and so on. LMNA gene might be a candidate of genetic basis in cryptogenic MGN.

Entities:  

Keywords:  Dilated cardiomyopathy; LMNA; Lamin A/C; Membranous glomerulonephritis

Year:  2018        PMID： 29349732      PMCID： PMC5886934          DOI： 10.1007/s13730-018-0303-8

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN： 2192-4449


  8 in total

Review 1.  Nuclear lamins: laminopathies and their role in premature ageing.

Authors:  J L V Broers; F C S Ramaekers; G Bonne; R Ben Yaou; C J Hutchison
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

2.  Amiodarone-related pulmonary mass and unique membranous glomerulonephritis in a patient with valvular heart disease: Diagnostic pitfall and new findings.

Authors:  Tokuhiro Kimura; Shigeru Kuramochi; Takaharu Katayama; Tsutomu Yoshikawa; Taketo Yamada; Yoshihiko Ueda; Yasunori Okada
Journal:  Pathol Int       Date:  2008-10       Impact factor: 2.534

3.  Partial lipodystrophy associated with a type 3 form of membranoproliferative glomerulonephritis.

Authors:  S Chartier; J B Buzzanga; F Paquin
Journal:  J Am Acad Dermatol       Date:  1987-01       Impact factor: 11.527

4.  Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia.

Authors:  D K Peters; J A Charlesworth; J G Sissons; D G Williams; J M Boulton-Jones; D J Evans; O Kourilsky; L Morel-Maroger
Journal:  Lancet       Date:  1973-09-08       Impact factor: 79.321

5.  Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.

Authors:  Horia C Stanescu; Mauricio Arcos-Burgos; Alan Medlar; Detlef Bockenhauer; Anna Kottgen; Liviu Dragomirescu; Catalin Voinescu; Naina Patel; Kerra Pearce; Mike Hubank; Henry A F Stephens; Valerie Laundy; Sandosh Padmanabhan; Anna Zawadzka; Julia M Hofstra; Marieke J H Coenen; Martin den Heijer; Lambertus A L M Kiemeney; Delphine Bacq-Daian; Benedicte Stengel; Stephen H Powis; Paul Brenchley; John Feehally; Andrew J Rees; Hanna Debiec; Jack F M Wetzels; Pierre Ronco; Peter W Mathieson; Robert Kleta
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

6.  Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy.

Authors:  Edward D Javor; Stephanie Ann Moran; Janice Ryan Young; Elaine K Cochran; Alex M DePaoli; Elif Arioglu Oral; Martin A Turman; Piers R Blackett; David B Savage; Stephen O'Rahilly; James E Balow; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

7.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

8.  Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome).

Authors:  Katharine R Owen; Mollie Donohoe; Sian Ellard; Tom J Clarke; Anthony J Nicholls; Andrew T Hattersley; Coralie Bingham
Journal:  Nephron Clin Pract       Date:  2004
  8 in total
  1 in total

1.  DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies.

Authors:  Julien L P Morival; Halida P Widyastuti; Cecilia H H Nguyen; Michael V Zaragoza; Timothy L Downing
Journal:  Clin Epigenetics       Date:  2021-07-10       Impact factor: 7.259
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.